STBCi063-A-1

SFC856-03-04 PINK1-/-A12

General

Cell Line

hPSCreg name STBCi063-A-1
Cite as:
STBCi063-A-1
Alternative name(s)
SFC856-03-04 PINK1-/-A12
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
STBCi063-A
(SFC856-03-04)
WIBRe001-A-78
(WIBR3_PINK1_Q129X_C4-1)
WIBRe001-A-80
(WIBR3_PINK1_Q129X_E7-1)
CBIGi001-A-8
(IPSC0071, PINK1-3flag/AIW002-02)
STBCi063-A-2
(SFC856-03-04 STING-/-F11D1)
STBCi063-B
(SFC856-03-07)
STBCi063-C
(SFC856-03-08)
CBIGi007-A-1
(IPSC0009, TMEM175 Q65Q homozygous correction)
Donor's gene variants:
TMEM175, TMEM175
Donor diseases:
Parkinson Disease
CBIGi007-A-2
(IPSC0010, TMEM175 P65P homozygous disease)
Donor's gene variants:
TMEM175, TMEM175
Donor diseases:
Parkinson Disease
CBIGi009-A-1
(IPSC0013, TMEM175 M393T homozygous correction)
Donor's gene variants:
TMEM175, TMEM175
Donor diseases:
Parkinson Disease
CBIGi013-A-1
(LRRK2 M1646T correction, IPSC0018)
Donor's gene variants:
LRRK2, LRRK2
Donor diseases:
Parkinson Disease
CBIGi027-A-1
(IPSC0039, LRRK2 G2385R (CBIGi027) correction)
Donor's gene variants:
LRRK2, LRRK2
Donor diseases:
Parkinson Disease
STBCi004-B-1
(SFC832-03-06 LRRK2WT/WT C47)
Donor's gene variants:
LRRK2
Donor diseases:
Parkinson disease
EDi001-A-1
(AST22-C, AST23-C)
Donor's gene variants:
SNCA, SNCA
Donor diseases:
Parkinson disease
EDi001-A-2
(AST23-1KO-3, AST22-1KO-3, AST-23_SCAKO Clone 3, AST-22_SNCAKO Clone 3)
Donor's gene variants:
SNCA, SNCA, SNCA, SNCA
Donor diseases:
Parkinson disease
EDi001-A-3
(AST23_SNCAKO Clone 1, AST22-1KO-1, AST23-1KO-1, AST22_SNCAKO Clone 1)
Donor's gene variants:
SNCA, SNCA, SNCA, SNCA
Donor diseases:
Parkinson disease
EDi001-A-4
(AST22-2KO-6, AST23_SNCAKO Clone 6, AST22_SNCAKO Clone 6, AST23-2KO-6)
Donor's gene variants:
SNCA, SNCA, SNCA, SNCA
Donor diseases:
Parkinson disease
MPIi003-A-1
(IM2GC, L2-2GC)
Donor diseases:
obsolete_Parkinson's disease
EDi001-B-1
(AST18-7A)
Donor's gene variants:
SNCA
Donor diseases:
Parkinson disease
EDi001-B-2
(AST18-7B)
Donor's gene variants:
SNCA
Donor diseases:
Parkinson disease
EDi001-B-3
(AST18-5D)
Donor's gene variants:
SNCA
Donor diseases:
Parkinson disease
EDi001-B-4
(AST18-6A)
Donor's gene variants:
SNCA
Donor diseases:
Parkinson disease
EDi001-A-5
(AST23-2KO-II8B)
Donor's gene variants:
SNCA
Donor diseases:
Parkinson disease
LCSBi009-A-1
(RHOT1_R272Q_clone18_IsogenicControl)
Donor diseases:
Parkinson Disease
LCSBi010-A-1
(RHOT1_R450C_clone6_IsogenicControl)
Donor diseases:
Parkinson Disease
LCSBi010-A-2
(RHOT1_R450C_clone10_IsogenicControl)
Donor diseases:
Parkinson Disease
CBIGi006-A-1
(IPSC0007, LRRK2 G2019S-correction)
Donor diseases:
Parkinson Disease
LCSBi012-A-1
(RHOT1_T610A_clone62.19.37_IsogenicControl)
Donor diseases:
Parkinson Disease
SUSMi005-A-1
(SNCA3X 0KO C1, SNCA3X 0KO C2)
Donor diseases:
obsolete_Parkinson's disease
SUSMi005-A-2
(SNCA3X 1KO C2, SNCA3X 1KO C1)
Donor diseases:
obsolete_Parkinson's disease
SUSMi005-A-3
(SNCA3X 2KO C1, SNCA3X 2KO C2)
Donor diseases:
obsolete_Parkinson's disease
SUSMi005-A-4
(SNCA3X 3KO C1, SNCA3X 3KO C2)
Donor diseases:
obsolete_Parkinson's disease
SUSMi005-A-5
(SNCA3X 4KO C1, SNCA3X 4KO C2)
Donor diseases:
obsolete_Parkinson's disease
LCSBi008-A-1
(delP GC13, DJ-1-delP GC13)
Donor diseases:
Parkinson Disease
CBIGi039-A-1
(IPSC0051, LRRK2 R1441H(CBIGi039-A) correction)
Donor's gene variants:
LRRK2, LRRK2
Donor diseases:
Parkinson Disease
CBIGi041-A-1
(IPSC0054, GBA L444P (CBIGi041-A) correction)
Donor's gene variants:
GBA, GBA
Donor diseases:
Parkinson Disease
CBIGi042-A-1
(GBA E326K (CBIGi042-A) correction, IPSC0056)
Donor's gene variants:
GBA, GBA
Donor diseases:
Parkinson Disease
CBIGi044-A-1
(IPSC0059, LRRK2 N551K (CBIGi044-A) correction)
Donor's gene variants:
LRRK2, LRRK2
Donor diseases:
Parkinson Disease
CBIGi044-A-2
(IPSC0060, LRRK2 R1398H (CBIGi044-A) correction)
Donor's gene variants:
LRRK2, LRRK2
Donor diseases:
Parkinson Disease
ICGi015-B-1
(m6.7pCyto-17)
Donor diseases:
Parkinson Disease
ICGi015-B-2
(m6.7pCyto-21)
Donor diseases:
Parkinson Disease
ICGi015-B-3
(m6.7pCyto-24)
Donor diseases:
Parkinson Disease
ICGi043-A-1
(LR-21-cytoGRX-3c)
Donor's gene variants:
LRRK2
Donor diseases:
Parkinson Disease
ICGi034-A-1
(PD30-XBP-RFP-6, PD30-4-7-XBP-RFP-6)
Donor diseases:
obsolete_Parkinson's disease
ICGi034-A-2
(PD30-4-7-XBP-RFP-51, PD30-XBP-RFP-51)
Donor diseases:
obsolete_Parkinson's disease
LCSBi011-A-1
(RHOT1_T351A_clone25.2_IsogenicControl)
Donor diseases:
Parkinson Disease
Last update 27th November 2024
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator University of Oxford (UOXF)
Owner University of Oxford (UOXF)
Derivation country United Kingdom

External Databases

BioSamples SAMEA117398111

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
Subclone of

Donor Information

General Donor Information

Sex female

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.

Donor Relations

Other cell lines of this donor

External Databases (Donor)

BioSamples SAMEA104493790

Ethics

Also have a look at the ethics information for the parental line STBCi063-A .
Is there an MTA available for the cell line? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

The source cell information can be found in the parental cell line STBCi063-A.

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Is reprogramming vector detectable?
No
Methods used
PCR
Notes on reprogramming vector detection see parent cell line SFC856-03-04 STBCi063-A for details and result

Vector free reprogramming

Other

Derived under xeno-free conditions
No
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzyme-free cell dissociation
EDTA
O2 Concentration 20 %
CO2 Concentration 5 %
Medium mTeSR™ 1
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

No characterisation data could be found for this subclone. Please open parental cell line STBCi063-A .

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
Normal Karyotype, same as parental line SFC856-03-04 STBCi063-A
Karyotyping method: Molecular karyotyping by SNP array
http://

Other Genotyping (Cell Line)

Genetic Modification

Disease/phenotype related modifications
Synonyms
  • Parkinson Disease
  • Parkinson's disease
  • Parkinson's Disease
Genetic modifications
PINK1 (target)
Gene knock-out
cytoband location: 1p36.12
Confirmation of bi-allelic edit at the genome level (PCR and sequencing across deletion), and at the functional level (lack of phosphorylation of Ubiquitin in PINK1 KO line versus parent line in derived neurons following CCCP treatment).
CRISPR-associated (CRISPR/Cas) System
SFC856-03-04 PINK1 KO A12 PCR.pdf
SFC856-03-04 PINK1 KO A12 PCR across deletion
SFC856-03-04 PINK1 KO A12 assay.pdf
SFC856-03-04 PINK1 KO A12 functional assay